Latest Posters

This poster explores how advanced automation tools can address these challenges, enabling clinical biobanks to improve compliance, optimize space and streamline operations for diverse sample sets.

This poster highlights how IMC technology deciphers the phenotypic and spatial characteristics of brain tumors, providing critical neuro-oncological insights.

This poster outlines the optimal parameters for PCR-free WGS library preparation, evaluating eight commercially available solutions and comparing the sequencing data quality generated by each.

This poster outlines a scalable workflow combining tangential flow filtration and size exclusion chromatography to effectively isolate and purify exosomes, removing contaminants including media, serum and host cell proteins, DNA and serum components.

This poster describes an optimized target enrichment protocol designed to enhance the capture and conversion of fragmented cfDNA for reliable NGS.

This poster is the perfect guide for selecting the optimal fluorescent dye for your cell imaging system based on their spectral properties, brightness and photostability.

This poster describes the use of CRISPR-ready iPSCs, which are engineered to constitutively express Cas9, enabling the rapid generation of high-efficiency gene knockouts and CRISPR screens in a functional, physiologically relevant cell background.

This poster details a resin-based approach employing immobilized caprylic acid, to effectively eliminate high aggregate levels along with host cell protein residues, for enhanced monoclonal antibody purification.

This poster demonstrates how a novel, precise and highly controlled iPSC reprogramming technology overcomes these limitations and enables the generation of mature cell types and isogenic models of neurodegenerative disease.

Many promising drugs which show efficacy in animal models have failed in the clinic due to interspecies variance in nociception mechanisms. Hence, consistent, scalable human in vitro models are required to accelerate potential therapeutics to the clinic.